Download PDF
J Reconstr Microsurg 2022; 38(09): 742-748
DOI: 10.1055/s-0042-1749595
Original Article

Increased Opioid Consumption following DIEP Flap Breast Reconstruction: Effect of Depression and Anxiety

Pope Rodnoi 
1   Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas
,
Ryan M. Dickey 
1   Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas
,
Sumeet S. Teotia   *
1   Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas
,
Nicholas T. Haddock   *
1   Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background Enhanced Recovery After Surgery (ERAS) protocols have decreased postoperative opioid consumption and hospital length of stay in deep inferior epigastric perforator (DIEP) flap breast reconstruction. We aim to evaluate whether there needs to be further adjustments to best improve outcomes specifically in patients with a preexisting psychiatric condition.

Methods A retrospective review was performed of all patients that underwent DIEP flap breast reconstruction between October 2018 and September 2020. This includes all patients with the most recent ERAS protocol implementation of intraoperative transverse abdominal plane blocks with liposomal bupivacaine. We looked at patients with a psychiatric diagnosis at the time of surgery. Specifically, forms of depression and anxiety were the psychiatric diagnoses for these patients. We divided these patients into three groups: those with no diagnoses, those with a single diagnosis, and those with both diagnoses. Primary outcomes observed were postoperative opioid consumption and length of stay. A one-way analysis of variance determined whether there was a difference between the three groups and a Tukey post hoc analysis made pairwise comparisons. A p-value of < 0.05 was significant.

Results A total of 176 patients were analyzed in this study: 59 (33.5%) of our study population had a diagnosis of either depression, anxiety, or both. Postoperative opioid consumption was higher in patients with a psychiatric diagnosis compared with those without (123.8 to 91.5; p < 0.0005). A multiple regression model consisting of operating time, hospital length of stay, whether the patient has a psychiatric diagnosis, and history of chemotherapy statistically significantly predicted opioid consumption (p < 0.0005).

Conclusion With similar hospital length of stay postoperatively, it is notable that patients with a psychiatric diagnosis had significantly higher amounts of postoperative opioid consumption. This study highlights the need to further improve multidisciplinary integrated care for patients with psychiatric comorbidities to improve pain management postoperatively.

Keywords

DIEP - depression and anxiety - opioid

* Senior Authors.




Publication History

Received: 29 September 2021

Accepted: 22 March 2022

Article published online:
17 June 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Schneider S, Armbrust R, Spies C, du Bois A, Sehouli J. Prehabilitation programs and ERAS protocols in gynecological oncology: a comprehensive review. Arch Gynecol Obstet 2020; 301 (02) 315-326
    CrossrefPubMedGoogle Scholar
  • 2 Goesling J, Lin LA, Clauw DJ. Psychiatry and pain management: at the intersection of chronic pain and mental Health. Curr Psychiatry Rep 2018; 20 (02) 12
    CrossrefPubMedGoogle Scholar
  • 3 Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain 2011; 12 (09) 964-973
    CrossrefPubMedGoogle Scholar
  • 4 Braden JB, Sullivan MD, Ray GT. et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry 2009; 31 (06) 564-570
    CrossrefPubMedGoogle Scholar
  • 5 Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005; 119 (1-3): 95-103
    CrossrefPubMedGoogle Scholar
  • 6 Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006; 166 (19) 2087-2093
    CrossrefPubMedGoogle Scholar
  • 7 Davis MA, Lin LA, Liu H, Sites BD. Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med 2017; 30 (04) 407-417
    CrossrefPubMedGoogle Scholar
  • 8 Wunsch H, Wijeysundera DN, Passarella MA, Neuman MD. Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012. JAMA 2016; 315 (15) 1654-1657
    CrossrefPubMedGoogle Scholar
  • 9 Ladha KS, Neuman MD, Broms G. et al. Opioid prescribing after surgery in the United States, Canada, and Sweden. JAMA Netw Open 2019; 2 (09) e1910734
    CrossrefPubMedGoogle Scholar
  • 10 Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg 2017; 125 (05) 1733-1740
    CrossrefPubMedGoogle Scholar
  • 11 Offodile II AC, Gu C, Boukovalas S. et al. Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature. Breast Cancer Res Treat 2019; 173 (01) 65-77
    CrossrefPubMedGoogle Scholar
  • 12 Sebai ME, Siotos C, Payne RM. et al. Enhanced Recovery after Surgery Pathway for microsurgical breast reconstruction: a systematic review and meta-analysis. Plast Reconstr Surg 2019; 143 (03) 655-666
    CrossrefPubMedGoogle Scholar
  • 13 Soteropulos CE, Tang SYQ, Poore SO. Enhanced recovery after surgery in breast reconstruction: a systematic review. J Reconstr Microsurg 2019; 35 (09) 695-704
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Haddock NT, Garza R, Boyle CE, Liu Y, Teotia SS. Defining enhanced recovery pathway with or without liposomal bupivacaine in DIEP flap breast reconstruction. Plast Reconstr Surg 2021; 148 (05) 948-957
    CrossrefPubMedGoogle Scholar
  • 15 Lasheen W, Walsh D, Mahmoud F. et al. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain. Palliat Med 2010; 24 (01) 9-16
    CrossrefPubMedGoogle Scholar
  • 16 Nielsen S, Degenhardt L, Hoban B, Gisev N. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiol Drug Saf 2016; 25 (06) 733-737
    CrossrefPubMedGoogle Scholar
  • 17 Harris PA, Taylor R, Minor BL. et al; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208
    CrossrefPubMedGoogle Scholar
  • 18 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
    Google Scholar
  • 19 Corp I. IBM SPSS Statistics for Windows. Version 26.0 ed.. Armonk, NY: IBM Corp; 2019
    Google Scholar
  • 20 Afonso A, Oskar S, Tan KS. et al. Is enhanced recovery the new standard of care in microsurgical breast reconstruction?. Plast Reconstr Surg 2017; 139 (05) 1053-1061
    CrossrefPubMedGoogle Scholar
  • 21 Astanehe A, Temple-Oberle C, Nielsen M. et al. An enhanced recovery after surgery pathway for microvascular breast reconstruction is safe and effective. Plast Reconstr Surg Glob Open 2018; 6 (01) e1634
    CrossrefPubMedGoogle Scholar
  • 22 Batdorf NJ, Lemaine V, Lovely JK. et al. Enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg 2015; 68 (03) 395-402
    CrossrefPubMedGoogle Scholar
  • 23 Bonde C, Khorasani H, Eriksen K, Wolthers M, Kehlet H, Elberg J. Introducing the fast track surgery principles can reduce length of stay after autologous breast reconstruction using free flaps: a case control study. J Plast Surg Hand Surg 2015; 49 (06) 367-371
    CrossrefPubMedGoogle Scholar
  • 24 Kaoutzanis C, Ganesh Kumar N, O'Neill D. et al. Enhanced recovery pathway in microvascular autologous tissue-based breast reconstruction: should it become the standard of care?. Plast Reconstr Surg 2018; 141 (04) 841-851
    CrossrefPubMedGoogle Scholar
  • 25 Momeni A, Ramesh NK, Wan D, Nguyen D, Sorice SC. Postoperative analgesia after microsurgical breast reconstruction using liposomal bupivacaine (Exparel). Breast J 2019; 25 (05) 903-907
    CrossrefPubMedGoogle Scholar
  • 26 Oh C, Moriarty J, Borah BJ. et al. Cost analysis of enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg 2018; 71 (06) 819-826
    CrossrefPubMedGoogle Scholar
  • 27 Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med 2012; 172 (05) 425-430
    CrossrefPubMedGoogle Scholar
  • 28 Habib AS, Kertai MD, Cooter M, Greenup RA, Hwang S. Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study. Reg Anesth Pain Med 2019; 44 (02) 192-199
    CrossrefPubMedGoogle Scholar
  • 29 Blumer D, Heilbronn M. Chronic pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis 1982; 170 (07) 381-406
    CrossrefPubMedGoogle Scholar
  • 30 Haddock NT, Teotia SS. Deconstructing the reconstruction: evaluation of process and efficiency in deep inferior epigastric perforator flaps. Plast Reconstr Surg 2020; 145 (04) 717e-724e
    CrossrefPubMedGoogle Scholar
  • 31 Kroll SS, Sharma S, Koutz C. et al; Evans GRD. Postoperative morphine requirements of free TRAM and DIEP flaps. Plast Reconstr Surg 2001; 107 (02) 338-341
    CrossrefPubMedGoogle Scholar
  • 32 Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med 2016; 176 (09) 1286-1293
    CrossrefPubMedGoogle Scholar
  • 33 Becherer BE, Kamali P, Paul MA. et al. Prevalence of psychiatric comorbidities among women undergoing free tissue autologous breast reconstruction. J Surg Oncol 2017; 116 (07) 803-810
    CrossrefPubMedGoogle Scholar
  • 34 Tsaras K, Papathanasiou IV, Mitsi D. et al. Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev 2018; 19 (06) 1661-1669
    CrossrefPubMedGoogle Scholar
  • 35 Rodnoi P, Teotia SS, Haddock NT. Economic impact of refinements in ERAS pathways in DIEP flap breast reconstruction. J Reconstr Microsurg 2021
    PubMedGoogle Scholar
  • 36 Carroll I, Barelka P, Wang CK. et al. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg 2012; 115 (03) 694-702
    CrossrefPubMedGoogle Scholar
  • 37 Songer D. Psychotherapeutic approaches in the treatment of pain. Psychiatry (Edgmont) 2005; 2 (05) 19-24
    PubMedGoogle Scholar
  • 38 Haddock NT, Garza R, Boyle CE, Teotia SS. Observations from implementation of the ERAS protocol after DIEP flap breast reconstruction. J Reconstr Microsurg 2021
    PubMedGoogle Scholar